Study Summary
This trial is testing whether proton therapy can help people with ventricular tachycardia who have already had an implantable cardioverter defibrillator and catheter ablation.
- Arrhythmia
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: 2 years
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Proton Particle Therapy for Cardiac Arrhythmia
1 of 1
Experimental Treatment
10 Total Participants · 1 Treatment Group
Primary Treatment: Proton Particle Therapy · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any open slots within this trial for enrollees?
"According to the information displayed on clinicaltrials.gov, this trial is still in need of participants. This medical study was first published on March 19th 2021 and its most recent update took place on April 28th 2022." - Anonymous Online Contributor
Does this clinical research permit geriatric participation?
"This clinical trial is only open to individuals between 18-80 years of age. For younger patients, 8 trials are available; older participants can join 70 different studies." - Anonymous Online Contributor
How many participants have been approved to partake in this medical experiment?
"Absolutely, patient recruitment for the trial is still underway. The study was initially posted on March 19th 2021 and underwent its most recent update on April 28th 2022. As of now, 10 participants need to be enrolled from a single medical centre." - Anonymous Online Contributor
Who qualifies to take part in this clinical trial?
"Admittance requirements for this trial include having a diagnosis of arrhythmia and being between 18-80 years old. The study is expected to enroll around 10 participants." - Anonymous Online Contributor